Welcome to LookChem.com Sign In|Join Free
  • or

Encyclopedia

MLN-8237

Base Information Edit
MLN-8237

Synonyms:Alisertib

Suppliers and Price of MLN-8237
Supply Marketing:Edit
Business phase:
The product has achieved commercial mass production*data from LookChem market partment
Manufacturers and distributors:
  • Manufacture/Brand
  • Chemicals and raw materials
  • Packaging
  • price
  • Usbiological
  • MLN 8237
  • 5mg
  • $ 496.00
  • Medical Isotopes, Inc.
  • MLN8237(Contain10%DMSO)
  • 5 mg
  • $ 675.00
  • Matrix Scientific
  • 4-((9-Chloro-7-(2-fluoro-6-methoxyphenyl)-5H-benzo[c]pyrimido-[4,5-e]azepin-2-yl)amino)-2-methoxybenzoic acid 95+%
  • 250mg
  • $ 742.00
  • Matrix Scientific
  • 4-((9-Chloro-7-(2-fluoro-6-methoxyphenyl)-5H-benzo[c]pyrimido-[4,5-e]azepin-2-yl)amino)-2-methoxybenzoic acid 95+%
  • 1g
  • $ 1647.00
  • DC Chemicals
  • MLN8237(Alisertib) >98%
  • 1 g
  • $ 1800.00
  • DC Chemicals
  • MLN8237(Alisertib) >98%
  • 250 mg
  • $ 900.00
  • DC Chemicals
  • MLN8237(Alisertib) >98%
  • 100 mg
  • $ 450.00
  • Crysdot
  • Alisertib(MLN8237) 98+%
  • 50mg
  • $ 290.00
  • Crysdot
  • Alisertib(MLN8237) 98+%
  • 100mg
  • $ 450.00
  • ChemScene
  • Alisertib 99.84%
  • 200mg
  • $ 850.00
Total 73 raw suppliers
Chemical Property of MLN-8237 Edit
Chemical Property:
  • Boiling Point:729.134 °C at 760 mmHg 
  • PKA:4.07±0.10(Predicted) 
  • Flash Point:394.766 °C 
  • Density:1.438 g/cm3 
  • Storage Temp.:-20°C 
  • Solubility.:Soluble in DMSO (up to 5 mg/ml) 
Purity/Quality:

98%,99%, *data from raw suppliers

MLN 8237 *data from reagent suppliers

Safty Information:
  • Pictogram(s):  
  • Hazard Codes: 
MSDS Files:

SDS file from LookChem

Useful:
  • Description Alisertib (MLN8237) is a selective Aurora A inhibitor with IC50 of 1.2 nM in a cell-free assay. It has >200-fold higher selectivity for Aurora A than Aurora B. Phase 3. Alisertib (MLN8237, 1028486-01-2) is a highly selective and potent (IC50?= 1 nM) cell permeable inhibitor of Aurora A with off-target binding at GABAA?(IC50?= 490 nM).1?It disrupts the Aurora A-Myc complex leading to Myc degradation2?in Myc amplified neuroblastomas3?and p53-mutant human hepatocellular carcinoma cell4. Alisertib has been found to induce apoptosis and autophagy in breast cancer5?and melanoma6?cells?via?suppression of activation of the p38 MAPK pathway.
  • Uses An Aurora kinase inhibitor, used to treat patients with advanced solid tumors.
Technology Process of MLN-8237

There total 10 articles about MLN-8237 which guide to synthetic route it. The literature collected by LookChem mainly comes from the sharing of users and the free literature resources found by Internet computing technology. We keep the original model of the professional version of literature to make it easier and faster for users to retrieve and use. At the same time, we analyze and calculate the most feasible synthesis route with the highest yield for your reference as below:

synthetic route:
Guidance literature:
4-{[amino(imino)methyl]amino}-2-methoxybenzoic acid hydrochloride; 8-chloro-4-[(dimethylamino)methylene]-1-(2-fluoro-6-methoxyphenyl)-3,4-dihydro-5H-2-benzazepin-5-one; With potassium carbonate; In methanol; at 50 - 55 ℃; for 24h;
With hydrogenchloride; In methanol; water; at 20 - 55 ℃; for 2h; pH=3;
Guidance literature:
Multi-step reaction with 4 steps
1.1: tert-butyl methyl ether; methanol / 3.5 h / 25 - 30 °C
2.1: diethylamine; copper(l) iodide / bis-triphenylphosphine-palladium(II) chloride / cyclohexane / 15 h / 28 - 33 °C / Inert atmosphere
3.1: trifluoroacetic acid / dichloromethane; water / 20 h / 20 - 35 °C
3.2: 2.5 h / 20 - 30 °C / pH 8
3.3: 20.5 h / 20 - 42 °C
4.1: potassium carbonate / methanol / 24 h / 50 - 55 °C
4.2: 2 h / 20 - 55 °C / pH 3
With copper(l) iodide; potassium carbonate; diethylamine; trifluoroacetic acid; bis-triphenylphosphine-palladium(II) chloride; In methanol; dichloromethane; tert-butyl methyl ether; cyclohexane; water;
Post RFQ for Price